- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 513/18 - Systèmes pontés
Détention brevets de la classe C07D 513/18
Brevets de cette classe: 139
Historique des publications depuis 10 ans
|
8
|
4
|
7
|
6
|
8
|
9
|
7
|
11
|
9
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20108 |
11 |
| City of Hope | 997 |
8 |
| Gilead Sciences, Inc. | 2056 |
8 |
| Colorado State University Research Foundation | 711 |
7 |
| Mutabilis | 27 |
6 |
| Daiichi Sankyo Company, Limited | 1877 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2596 |
5 |
| University of Notre Dame du Lac | 578 |
5 |
| Pfizer Inc. | 3386 |
3 |
| University of Florida Research Foundation, Inc. | 4053 |
3 |
| Cetya Therapeutics, Inc. | 3 |
3 |
| Elanco Animal Health Ireland Limited | 3 |
3 |
| Oncodesign S.A. | 15 |
3 |
| Sanofi | 4097 |
3 |
| Novartis AG | 10721 |
2 |
| Bristol-myers Squibb Company | 4849 |
2 |
| Glaxosmithkline LLC | 535 |
2 |
| Janssen Pharmaceutica N.V. | 3367 |
2 |
| Wisconsin Alumni Research Foundation | 3884 |
2 |
| Takeda Pharmaceutical Company Limited | 2710 |
2 |
| Autres propriétaires | 54 |